These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. Andrews CJ, Somerville B. Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384 [No Abstract] [Full Text] [Related]
3. Letter: Lithium and haloperidol in movement disorders. McCaul JA, Stern GM. Lancet; 1974 May 25; 1(7865):1058. PubMed ID: 4133743 [No Abstract] [Full Text] [Related]
4. Letter: Lithium and M.R.I.H. in tardive dyskinesia. Ehrensing RH. Lancet; 1974 Dec 14; 2(7894):1459-60. PubMed ID: 4140382 [No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's disease with L-dopa. 77 cases]. Boudin G, Castaigne P, Lhermitte F, Beck H, Guillard A, Marteau R, Pepin B, Rondot P, Raphy B. Rev Neurol (Paris); 1970 Feb 14; 122(2):89-102. PubMed ID: 4931719 [No Abstract] [Full Text] [Related]
6. [Clinical study of L-dopa in Parkinson's disease]. Franken L, Noel G, Lhoas JP, Meyers C, Noel P, Ectors M. Brux Med; 1972 Dec 14; 52(12):851-60. PubMed ID: 4575350 [No Abstract] [Full Text] [Related]
7. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports]. Rosati G, Agnetti V, Mura F, Granieri E. Minerva Med; 1974 May 02; 65(33):1811-23. PubMed ID: 4602058 [No Abstract] [Full Text] [Related]
8. L-Dopa treatment in Parkinson's Disease. Rinne UK, Sonninen V, Siirtola T. Eur Neurol; 1970 May 02; 4(6):348-69. PubMed ID: 4932969 [No Abstract] [Full Text] [Related]
9. [Results of the treatment of Parkinson's diseases with carbidopa and L-Dopa]. Cáceres AF. Rev Fac Cienc Med Cordoba; 1974 May 02; 32(2):161-74. PubMed ID: 4619691 [No Abstract] [Full Text] [Related]
10. Letter: Pyridoxine in parkinsonism. Lancet; 1973 Nov 03; 302(7836):1029-30. PubMed ID: 4127254 [No Abstract] [Full Text] [Related]
11. [Results of treatment with levodopa and rehabilitative therapy in 10 cases of Parkinson's disease]. Paciaroni E, Raspa EG. Sist Nerv; 1970 Nov 03; 22(2):153-61. PubMed ID: 5504554 [No Abstract] [Full Text] [Related]
12. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University). Gutmann L, Martin JD, Gutrecht JA. W V Med J; 1970 Apr 03; 66(4):109-11. PubMed ID: 5264660 [No Abstract] [Full Text] [Related]
13. Parkinson's disease treated with L-dopa. Three-year follow-up report. Mones RJ. N Y State J Med; 1972 Nov 15; 72(22):2749-50. PubMed ID: 4510706 [No Abstract] [Full Text] [Related]
14. [Preliminary impressions of the therapeutic effectiveness of L-dopa in Parkinson's disease]. Buscaino GA, Campanella G. Sist Nerv; 1970 Nov 15; 22(2):82-91. PubMed ID: 5504561 [No Abstract] [Full Text] [Related]
15. [10 years of L-DOPA therapy of Parkinson's syndrome]. Birkmayer W. Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333 [No Abstract] [Full Text] [Related]
16. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study]. Tissot R, de Ajuriaguerra J. Nouv Presse Med; 1973 Feb 03; 2(5):315-6. PubMed ID: 4686226 [No Abstract] [Full Text] [Related]
17. L-dopa induced dyskinesias in 152 patients with Parkinson's disease. Mones RJ, Elizan TS, Siegel G. Trans Am Neurol Assoc; 1970 Feb 03; 95():286-7. PubMed ID: 5514393 [No Abstract] [Full Text] [Related]